CA
NZ
UK
AU
IND
US
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of common stock in Albemarle Corp, the Charlotte, North Carolina-based specialty chemicals company, as of a reporting event dated September 30, 2026.
Law firm Bleichmar Fonti & Auld LLP announced on November 10, 2026, that a securities fraud class action lawsuit has been filed against Kinross Gold Corporation and certain of its senior executives in the U.S. District Court for the District of Colorado.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 33,523,019 shares of Accenture PLC common stock, representing 5.5% of the class, as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 13,675,348 shares of ADMA Biologics Inc. common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 3,581,089 shares of Allegion PLC common stock as of September 30, 2026.
Fervo Energy Company filed its Form 10-Q with the SEC on November 10, 2026, covering the quarterly period ended September 30, 2026, its first quarterly report as a publicly traded company following its initial public offering earlier in 2026.
A Schedule 13G was filed on November 10, 2026, by Wang Guanran and three affiliated entities disclosing beneficial ownership of ordinary shares of Londian Wason New Energy Tech Inc. as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 837,797 shares of Alpha Metallurgical Resources Inc common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of shares of Allogene Therapeutics Inc. common stock as of September 30, 2026.
Marcus Jewell, an officer of Cellebrite DI Ltd., filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 31,728 ordinary shares on NASDAQ scheduled for November 16, 2026.
Please wait processing your request...